You are here: Industry Insights > neurology

News List

GSK and Alector announce global collaboration in immuno-neurology worldpharmanews
July 05, 2021
GlaxoSmithKline plc and Alector, announced a strategic global collaboration for the development and commercialisation of two clinical-stage, potential first-in-class monoclonal antibodies (AL001 and AL101) designed to elevate progranulin (PGRN) levels.
Argenx Announces Publication of Phase 3 ADAPT Trial Results of Efgartigimod for the Treatment of Generalized Myasthenia Gravis in The Lancet Neurology firstwordpharma
June 17, 2021
argenx (Euronext & Nasdaq: ARGX), today announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living with generalized myasthenia gravis (gMG).
Qynapse to present clinical results of QyScore® for Alzheimer's Disease and Multiple Sclerosis at the 7th Congress of the European Academy of Neurology prnasia
June 16, 2021
QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, today announced it will present clinical data on QyScore® for Alzheimer's disease and multiple sclerosis at the 7th Congress of ...
Servier and MiNA Therapeutics ink neurology pact pharmatimes
January 25, 2021
French pharma company Servier has entered into a research partnership with UK biotech MiNA Therapeutics to develop small activating RNA (saRNA) therapies for the treatment of neurological diseases.
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology prnasia
December 25, 2019
The results generated in the U.S. Evoke Pivotal Study demonstrate that the spinal cord response to stimulation can be successfully measured and used to adjust stimulation to maintain spinal cord activation within the patient-specific therapeutic window.
World Federation of Neurology Joins Forces with the World Health Organization, Announcing "Groundbreaking" Reclassification of Stroke as a Disorder of the Brain; Launches Nine-Country Survey, Leading to Roadmap for Improved Neurological Care En-CPhI.CN
October 29, 2019
The World Federation of Neurology (WFN) is joining forces with the World Health Organization (WHO) to create global standards of neurological care.
New Research on Climate Change and the Brain, the Relationship Between Stroke and Dementia, Advances in Epilepsy and MS Among the Brain Health Initiatives Unveiled at 24th World Congress of Neurology En-CPhI.CN
October 23, 2019
Promising scientific research on the impact of climate change on brain health, advancements in epilepsy and multiple sclerosis, the relationship between stroke and dementia ...
Dr. Reddy's enters into a definitive agreement to sell its neurology branded products to Upsher Smith Laboratories biospectrumasia
June 16, 2019
Under the agreement, Dr. Reddy’s will receive U.S.$70 million as upfront consideration, U.S.$40.5 million in near term milestones and additional financial considerations including existing contractual obligation and inventory.
DRL to sell neurology branded products to Upsher-Smith Laboratories expressbpd
June 14, 2019
Dr Reddy’s would sell its US and select territory rights for ZEMBRACE SYMTOUCH and TOSYMRATM, which are commercialized through its wholly-owned subsidiary, Promius Pharma
American Academy of Neurology, May 4-10 drugs
May 15, 2019
American Academy of Neurology, May 4-10.